id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
HHS-OASH-2023-0003-0018,HHS,HHS-OASH-2023-0003,Draft comments on FDA pediatric guidance 03.23.2023 SACHRP edits_,Supporting & Related Material,,2023-03-23T04:00:00Z,2023,3,,,2023-03-23T13:52:33Z,,0,0,0900006485832641
HHS-OASH-2023-0003-0016,HHS,HHS-OASH-2023-0003,SOH Public Roster 3.23,Supporting & Related Material,,2023-03-22T04:00:00Z,2023,3,,,2023-03-22T12:24:07Z,,0,0,0900006485814de9
HHS-OASH-2023-0003-0014,HHS,HHS-OASH-2023-0003,Engaging key stakeholders to overcome barriers to studying quality of research ethics oversight,Supporting & Related Material,,2023-03-22T04:00:00Z,2023,3,,,2023-03-22T12:21:23Z,,0,0,090000648582184b
HHS-OASH-2023-0003-0015,HHS,HHS-OASH-2023-0003,Weiner Comments for SACHRP Meeting 3.22-23.2023,Supporting & Related Material,,2023-03-22T04:00:00Z,2023,3,,,2023-03-22T12:23:38Z,,0,0,0900006485814de8
HHS-OASH-2023-0003-0017,HHS,HHS-OASH-2023-0003,SAS Public Roster_3_23,Supporting & Related Material,,2023-03-22T04:00:00Z,2023,3,,,2023-03-22T12:44:27Z,,0,0,0900006485814de7
HHS-OASH-2023-0003-0013,HHS,HHS-OASH-2023-0003,SACHRP March 2023 - AEREO and the GAO Report,Supporting & Related Material,,2023-03-21T04:00:00Z,2023,3,,,2023-03-21T13:34:43Z,,0,0,090000648581051d
HHS-OASH-2023-0003-0012,HHS,HHS-OASH-2023-0003,GAO slides.SACHRP.3.12.23,Supporting & Related Material,,2023-03-14T04:00:00Z,2023,3,,,2023-03-14T16:40:06Z,,0,0,09000064857a79ee
HHS-OASH-2023-0003-0011,HHS,HHS-OASH-2023-0003,Panel biosketch,Supporting & Related Material,,2023-03-13T04:00:00Z,2023,3,,,2023-03-13T19:34:36Z,,0,0,09000064857a0789
HHS-OASH-2023-0003-0003,HHS,HHS-OASH-2023-0003,GAO SACHRP charge _March 2023,Supporting & Related Material,,2023-03-13T04:00:00Z,2023,3,,,2023-03-13T14:08:35Z,,0,0,090000648579bd87
HHS-OASH-2023-0003-0002,HHS,HHS-OASH-2023-0003,SACHRP EXO Roster Oct 2022,Supporting & Related Material,,2023-03-13T04:00:00Z,2023,3,,,2023-03-13T14:08:25Z,,0,0,090000648579bd86
HHS-OASH-2023-0003-0010,HHS,HHS-OASH-2023-0003,Draft comments on FDA pediatric guidance 03.10.2023,Supporting & Related Material,,2023-03-13T04:00:00Z,2023,3,,,2023-03-13T19:34:27Z,,0,0,09000064857a0788
HHS-OASH-2023-0003-0004,HHS,HHS-OASH-2023-0003,SACHRP Agenda March 2023_3.6.23 (003),Supporting & Related Material,,2023-03-13T04:00:00Z,2023,3,,,2023-03-13T14:08:46Z,,0,0,090000648579b4f6
HHS-OASH-2023-0003-0008,HHS,HHS-OASH-2023-0003,gao-23-104721,Supporting & Related Material,,2023-03-13T04:00:00Z,2023,3,,,2023-03-13T14:09:44Z,,0,0,090000648579b4fa
HHS-OASH-2023-0003-0006,HHS,HHS-OASH-2023-0003,gao-23-104721-highlights,Supporting & Related Material,,2023-03-13T04:00:00Z,2023,3,,,2023-03-13T14:09:28Z,,0,0,090000648579b4f8
HHS-OASH-2023-0003-0009,HHS,HHS-OASH-2023-0003,gao-23-104721 accessible,Supporting & Related Material,,2023-03-13T04:00:00Z,2023,3,,,2023-03-13T14:09:53Z,,0,0,090000648579b4fb
HHS-OASH-2023-0003-0001,HHS,HHS-OASH-2023-0003,SACHRP EXO Roster March 2023,Supporting & Related Material,,2023-03-13T04:00:00Z,2023,3,,,2023-03-13T14:08:15Z,,0,0,090000648579bd85
HHS-OASH-2023-0003-0005,HHS,HHS-OASH-2023-0003,SACHRP Roster March 2023,Supporting & Related Material,,2023-03-13T04:00:00Z,2023,3,,,2023-03-13T14:08:57Z,,0,0,090000648579b4f7
HHS-OASH-2023-0003-0007,HHS,HHS-OASH-2023-0003,2019-89-DG- Ethical Consideratons for Clinical Investigations of Medical Products Involving Children (9-19-22) (1),Supporting & Related Material,,2023-03-13T04:00:00Z,2023,3,,,2023-03-13T14:09:36Z,,0,0,090000648579b4f9